Study of acute chagasic mice under immunosuppressive therapy by cyclosporin A: Modulation and confocal analysis of inflammatory reaction

Immunopharmacology

Volumn 47, Issue 1, 2000, Pages 1-11

  Calabrese, K S ^a   Paradela, A S R C ^a   Zaverucha Do Valle, T ^a   Tedesco, R C ^b   Silva, S ^b   Mortara, R A ^b   Goncalves Da Costa S C ^a  

^a Depto Helmintologia Inst O   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute Chagas' disease; Confocal microscopy; Cyclosporin A; Immunosuppression; Inflammatory reaction; Murine model; Trypanosoma cruzi

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHAGAS DISEASE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MACROPHAGE; MONONUCLEAR CELL; MORTALITY; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; SPLEEN; THYMUS; TIME OF DEATH; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHAGAS DISEASE; CYCLOSPORINE; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KINETICS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MACROPHAGES; MICE; MICROSCOPY, CONFOCAL; MONOCYTES; MYOCARDITIS; MYOCARDIUM; ORGAN SIZE; PARASITEMIA; SPLEEN; THYMUS GLAND; TIME FACTORS; TRYPANOSOMIASIS;

EID: 0033994679     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00179-4     Document Type: Article

References (43)

1. Abrahamsohn I.A., Coffman R.L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 155:1995;3955-3959.
2. Andrade Z., Andrade S.G., Sadigursky M. Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of Cyclophosphamide. Am. J. Pathol. 127(3):1987;467-473.
3. Bocchi E.A. Imunossupressão na doença de Chagas. Aspectos clínicos-cardiológicos na imunossupressão. Rev. Soc. Bras. Med. Trop. 20:1987;M39-M40. Suppl.
4. Borel J.F., Robert O. La ciclosporine. La Recherche. 20(211):1989;711-763.
5. Borel J.F., Wiesinger D. Studies on the mechanism of action of cyclosporin A. Br. J. Pharmacol. 66(1):1979;66P-67P.
6. Calabrese K.S., Bauer P.G., Gonçalves da Costa S.C. Evolution and distribution of Trypanosoma cruzi in some organs of Cyclophosphamide treated mice. Mem. Inst. Oswaldo Cruz. 82(Suppl. II):1987;47.
7. Calabrese K.S., Lagrange P.H., Gonçalves da Costa S.C. Chagas' disease: enhancement of systemic of inflammatory reaction in cyclophosphamide treated mice. Int. J. Immunopharmacol. 18:1996;505-514.
8. Calne R.Y. Immunosuppression for organ graftin-observations on cyclosporin A. Immunol. Rev. 46:1979;113-124.
9. Carson F.L., Martin D.H., Lynn D.A. Formalin fixation for electron microscopy: a re-evaluation. Am. J. Clin. Pathol. 59:1973;365.
10. Cole G.A., Nickell S.P., Mokhtarian F., Scheibel L.W. Effects of cyclosporine on experimental infections. Transplant Proc. 15(suppl. 1):1983;2271-2277.
11. Dias, J.C.P., Coura, J.R., 1997. Epidemiologia. In: Dias, J.C.P., Coura, J.R. (Eds.), Clínica e Terapêutica da Doença de Chagas: Uma Abordagem Prática para o Clínico Geral, Rio de Janeiro, FIOCRUZ, pp. 33-36.
12. Drath D.B., Kahan B.D. Alteration in rat pulmonary macrophage function by the immunosuppressive agents cyclosporine, azathioprine and prednisolon. Transplantation. 35:1983;588-592.
13. Espevik T., Figari I.S., Shalaby M.R., Lackides G.A., Lewis G.D., Shepard H.M., Palladino M.A. Jr. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J. Exp. Med. 166:1987;571-576.
14. Ferreira M.S., Nishioka S.A., Silvestre M.T., Borges A.S., Nunes-Araujo F.R., Rocha A. Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin. Infect. Dis. 25(6):1997;1397-1400.
15. Gonçalves da Costa S.C., Lagrange P.H. Development of cell mediated immunity to flagellar antigens and acquired resistance to infection by Trypanosoma cruzi in mice. Mem. Inst. Oswaldo Cruz. 76:1981;367-381.
16. Gonçalves da Costa S.C., Lagrange P.H., Hurtrel B., Kerr I., Alencar A. Role of the lymphocytes in the resistance and immunopathology of experimental Chagas' disease. Ann. Immunol. Inst. Pasteur (Paris). 135C:1984;317-332.
17. Hayes M.M., Kierszenbaum F. Experimental Chagas' disease: kinetics of lymphocyte response and immunological control of the transition from acute to chronic Trypanosoma cruzi infection. Infect. Immun. 31:1981;1117-1124.
18. + T-cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease. Eur. J. Immunol. 17:1987;1027-1033.
19. Kierszenbaum F. Chagas' disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 12(2):1999;210-223.
20. Kierszenbaum F., Gottlieb C.A., Budzko D.B. Exacerbation of Trypanosoma cruzi infection in mice treated with the immunoregulatory agent cyclosporin A. Tropenmed. Parasit. 34:1983;4-6.
21. Kim J.H., Perfect J.R. Infection and cyclosporine. Rev. Infect. Dis. 11(5):1989;677-690.
22. Krettli A.U., Brener Z. Protective effects of specific antibodies in Trypanosoma cruzi infection. Immunology. 116:1976;760-775.
23. Kumar R., Kline I.K., Abelmann W.H. Immunosuppression in experimental acute and subacute chagasic myocarditis. Am. J. Trop. Med. Hyg. 19:1970;932-939.
24. Lagrange P.H., Mackaness G.B. A stable form of delayed type hypersensitivity. J. Exp. Med. 141:1975;82.
25. Langeron, M., 1949. Précis de microscopie. In: Masson (Ed.), Paris.
26. Leiguarda R., Roncoroni A., Taratuto A.L., Jost L., Berthier M., Nogues M., Freilig H. Acute CNS infection by Trypanosoma cruzi (Chagas' disease) in immunosuppressed patients. Neurology. 40:1990;850-851.
27. Lidedell F.D.K. Evaluation of survival in challenge experiments. Am. Soc. Microbiol. 42:1978;237-249.
28. McCabe R.E., Remington J.S., Araujo F.G. In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 34:1985;861-865.
29. Milon G., Marchal G. Increased infiltration by monocytes in delayed type hypersensitivity site following cyclophosphamide treatment. Immunology. 35:1978;989-995.
30. Milon G., Truffa-Bachi P., Shidani B., Marchal G. Cyclosporin A inhibits the delayed-type hypersensitivity effector function of T lymphocytes without affecting their clonal expansion. Ann. Immunol. Inst. Pasteur (Paris). 135D:1984;237-245.
31. Nickell S.P., Scheibel L.W., Cole G.A. Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro. Infect. Immun. 37:1982;1093-1100.
32. Pereira da Silva L.H., Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para camundongos brancos. Folia Clin. Biol. (São Paulo). 20:1953;191-203.
33. Petry K., Eisen H. Chagas disease: a model for the study of autoimmune diseases. Parasitol. Today. 5(4):1989;111-116.
34. Pizzi, T., 1957. Immunologia de la enfermidad de Chagas. Thesis, Universidad de Chile, p. 183.
35. Rottenberg M.E., Bakkiert M., Olsson T., Kristensson K., Mark T., Wigzell H., Orn A. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infection with Trypanosoma cruzi or Trypanosoma brucei. Infect. Immun. 61:1993;5129.
36. Rocha A., Meneses C.A., da Silva A.M., Ferreira M.S., Nishioka S.A., Burgarelli M.K., Almeida E., Turcato G. Jr., Metze K., Lopes E.R. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am. J. Trop. Med. Hyg. 50(3):1994;261-268.
37. Russo M., Starobinas N., Minoprio P., Coutinho A., Hontebeyrie-Joskowicz M. Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi infected mice after inactivation of helper T-cells. Ann. Immunol. Inst. Pasteur (Paris). 139:1988;225-236.
38. Silva J.S., Rossi M.A. Intensification of acute Trypanosoma cruzi myocarditis in Balb/c mice pretreated with low dose of cyclophosphamide or gamma irradiation. Int. J. Pathol. 71:1990;33-39.
39. Stolf N.A.G., Higushi L., Bocchi E., Bellotti G., Auler J.O.C., Uip D., Neto A., Pileggi F., Adib D.J. Heart transplantation in patients with Chagas' disease cardiomyopathy. J. Heart Transpl. 6(5):1987;307-312.
40. + cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144(2):1990;717-724.
41. Thomson A.W., Webester L.A. The influence of cyclosporin A on cell-mediated immunity. Clin. Exp. Immunol. 71:1988;369-376.
42. Torres M. Sobre a anatomia patológica da doença de Chagas. Mem. Inst. Oswaldo Cruz. 36(3):1941;391-404.
43. Trischmann T.M. Role of cellular immunity in protection against Trypanosoma cruzi in mice. Parasite Immunol. 6:1984;561-570.